Simar Pal Singh
Overview
Explore the profile of Simar Pal Singh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
429
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dunlock V, Arp A, Singh S, Charrin S, Nguyen V, Jansen E, et al.
Cell Rep
. 2022 Jun;
39(13):111006.
PMID: 35767951
T cells depend on the phosphatase CD45 to initiate T cell receptor signaling. Although the critical role of CD45 in T cells is established, the mechanisms controlling function and localization...
2.
Rip J, de Bruijn M, Neys S, Singh S, Willar J, van Hulst J, et al.
Eur J Immunol
. 2021 Jul;
51(9):2251-2265.
PMID: 34323286
Bruton's tyrosine kinase (Btk) is a crucial signaling molecule in BCR signaling and a key regulator of B- cell differentiation and function. Btk inhibition has shown impressive clinical efficacy in...
3.
Dhoot S, Mittal S, Singh S, Patel V, Kasliwal R, Mehta V
Future Sci OA
. 2020 Jun;
6(5):FSO467.
PMID: 32518682
There is a very high prevalence of iron deficiency anemia in patients with systolic heart failure. The present study is a prospective, parallel, 1:1 randomized controlled trial of intravenous ferric-carboxy...
4.
Singh S, de Bruijn M, Velaso Gago da Graca C, Corneth O, Rip J, Stadhouders R, et al.
J Immunol
. 2019 Dec;
204(2):360-374.
PMID: 31836657
Balanced activity of kinases and phosphatases downstream of the BCR is essential for B cell differentiation and function and is disturbed in chronic lymphocytic leukemia (CLL). In this study, we...
5.
Singh S, Dammeijer F, Hendriks R
Mol Cancer
. 2019 Apr;
18(1):79.
PMID: 30943993
Following publication of the original article [1], the authors reported an error in Table 1.
6.
Rip J, de Bruijn M, Appelman M, Singh S, Hendriks R, Corneth O
Front Immunol
. 2019 Feb;
10:95.
PMID: 30761150
Bruton's tyrosine kinase (Btk) is a signaling molecule involved in development and activation of B cells through B-cell receptor (BCR) and Toll-like receptor (TLR) signaling. We have previously shown that...
7.
Singh S, de Bruijn M, de Almeida M, Meijers R, Nitschke L, Langerak A, et al.
Front Immunol
. 2018 Oct;
9:1996.
PMID: 30271400
Chronic lymphocytic leukemia (CLL) can be divided into prognostically distinct subsets with stereotyped or non-stereotyped, mutated or unmutated B cell receptors (BCRs). Individual subsets vary in antigen specificity and origin,...
8.
Singh S, Dammeijer F, Hendriks R
Mol Cancer
. 2018 Feb;
17(1):57.
PMID: 29455639
Bruton's tyrosine kinase (BTK) is a non-receptor kinase that plays a crucial role in oncogenic signaling that is critical for proliferation and survival of leukemic cells in many B cell...
9.
Singh S, Pillai S, de Bruijn M, Stadhouders R, Corneth O, van den Ham H, et al.
Oncotarget
. 2017 Oct;
8(42):71981-71995.
PMID: 29069762
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of mature CD5 B cells in blood. Spontaneous apoptosis of CLL cells has hampered in-depth investigation of CLL pathogenesis. Here we...
10.
Pedroza-Gonzalez A, Zhou G, Singh S, Boor P, Pan Q, Grunhagen D, et al.
Oncoimmunology
. 2015 Nov;
4(12):e1051297.
PMID: 26587321
In liver cancer tumor-infiltrating regulatory T cells (Ti-Treg) are potent suppressors of tumor-specific T-cell responses and express high levels of the Treg-associated molecules cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and...